UPDATE: BMO Capital Upgrades Regeneron Pharma (REGN) to Outperform
Tweet Send to a Friend
(Updated - January 25, 2021 12:32 AM EST)
BMO Capital analyst Matthew Luchini upgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Matthew Luchini upgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
